Big Move For Prelude Therapeutics Incorporated
Mon, Nov 03, 2025 at 07:08 PM
Prelude Therapeutics Incorporated (PRLD:NASDAQ) jumped higher at $3.98, representing a gain of 150.3%. On Mon, Nov 03, 2025, PRLD:NASDAQ touched a New 2-Week High of $3.98. The stock got featured on our News Catalysts scanner on Mon, Nov 03, 2025 at 11:24 AM in the 'MISCELLANEOUS' category. From Mon, Oct 20, 2025, the stock recorded 60.00% Up Days and 63.64% Green Days
About Prelude Therapeutics Incorporated (PRLD:NASDAQ)
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with...
Top 10 Gainers:
- Prelude Therapeutics Incorporated (PRLD:NASDAQ), 150.31%
- Resolute Holdings Management (RHLD:NYSE), 96.81%
- Resolute Holdings Management, Inc. (RHLD:NASDAQ), 96.81%
- Hempacco Co., Inc. (HPCO:NASDAQ), 80%
- Terns Pharmaceuticals, Inc. (TERN:NASDAQ), 69.85%
- Davis Commodities Limited (DTCK:NASDAQ), 66.84%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- Nautilus Biotechnology, Inc. (NAUT:NASDAQ), 39.1%
- Raytech Holding Limited (RAY:NASDAQ), 31.94%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 29.11%